CPT1A Gene Carnitine palmitoyltransferase 1A deficiency Genetic Test
Test Name: CPT1A Gene Carnitine palmitoyltransferase 1A deficiency Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CPT1A Gene Carnitine palmitoyltransferase 1A deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Carnitine palmitoyltransferase 1A deficiency.
Test Details
CPT1A gene (Carnitine palmitoyltransferase 1A) deficiency is a genetic disorder that affects the body’s ability to convert long-chain fatty acids into energy. This deficiency can lead to a buildup of fatty acids in tissues and organs, particularly in the liver, heart, and muscles.
NGS (Next-Generation Sequencing) Genetic Test is a diagnostic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of CPT1A deficiency, an NGS genetic test can identify mutations or variations in the CPT1A gene that may be responsible for the disorder. By analyzing the DNA sequence of the CPT1A gene, the NGS genetic test can provide valuable information about the specific genetic variants present in an individual.
This information can help healthcare professionals diagnose CPT1A deficiency and provide appropriate treatment and management strategies. It is important to note that the CPT1A deficiency NGS genetic test is a specialized test that should be ordered and interpreted by a qualified healthcare professional with expertise in genetics. The test results should be used in conjunction with clinical evaluation and other diagnostic tools to make an accurate diagnosis and guide patient care.
Test Name | CPT1A Gene Carnitine palmitoyltransferase 1A deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CPT1A Gene Carnitine palmitoyltransferase 1A deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Carnitine palmitoyltransferase 1A deficiency |
Test Details |
CPT1A gene (Carnitine palmitoyltransferase 1A) deficiency is a genetic disorder that affects the body’s ability to convert long-chain fatty acids into energy. This deficiency can lead to a buildup of fatty acids in tissues and organs, particularly in the liver, heart, and muscles. NGS (Next-Generation Sequencing) Genetic Test is a diagnostic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of CPT1A deficiency, an NGS genetic test can identify mutations or variations in the CPT1A gene that may be responsible for the disorder. By analyzing the DNA sequence of the CPT1A gene, the NGS genetic test can provide valuable information about the specific genetic variants present in an individual. This information can help healthcare professionals diagnose CPT1A deficiency and provide appropriate treatment and management strategies. It is important to note that the CPT1A deficiency NGS genetic test is a specialized test that should be ordered and interpreted by a qualified healthcare professional with expertise in genetics. The test results should be used in conjunction with clinical evaluation and other diagnostic tools to make an accurate diagnosis and guide patient care. |